Cloxacillin
As of the edition of 20 October 2026, Cloxacillin is a small molecule: marketed, first approved in 1965 (ES).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2011
- Kind
- Small molecule
- Brand name
- Tegopen
- First approved
- 1 February 1965 (ES)
- Approvals on record
- 5 in 4 regions
- Holder of the most recent approval
- Sterimax; 4 holders in all
- Registered trials
- 4, 1 stopped early
- Disease areas
- Blood and lymph; Cancer; Infections
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 2 | 0 | 0 |
| Phase 3 | 2 | 1 | 0 | 1 |
| All trials | 4 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Bristol Myers Squibb | Acquired holder | 2003 to now |
| Sterimax | Applicant | 2011 to now |